Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Garel

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Palliative & Supportive Care|October 23, 2025
Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case reportHouman Farzin, Benjamin Koren, Héléna Ferrier, et al.
Journal of Clinical Psychopharmacology|February 29, 2024
Rapid Improvement of Post-Partum Depression With Subanesthetic Racemic KetamineÉmilie Guay, Marie-Josée Brouillette, Jessica Drury, et al.
International Clinical Psychopharmacology|April 26, 2021
Adjunctive music improves the tolerability of intravenous ketamine for bipolar depressionKyle T Greenway, Nicolas Garel, Nathalie Goyette, et al.
Journal of Affective Disorders|June 1, 2024
The impact of antidepressant treatment on the network structure of neurocognition and core emotional depressive symptoms among depressed individuals with a history of suicide attempt: An 8-week clinical studyStéphane Richard-Devantoy, Marcelo T Berlim, Nicolas Garel, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 24, 2025
Effect of Cariprazine on Outcomes in Older-aged and Younger-aged Patients with Bipolar I Disorder: A Post-hoc AnalysisNicolas Garel, Annemieke Dols, Jun Yu, et al.
Journal of Psychiatry & Neuroscience : JPN|May 12, 2023
Mindfulness-based intervention for benzodiazepine deprescription in hemodialysis patients with anxiety and depressive symptomsNicolas Garel, Christina Rigas, Mona Ben M'rad, et al.
International Clinical Psychopharmacology|May 9, 2023
Ketamine for depression: a potential role in requests for Medical Aid in Dying?Nicolas Garel, Michka Nazon, Kamran Naghi, et al.
Expert Review of Clinical Pharmacology|January 27, 2025
The ketamine chameleon: history, pharmacology, and the contested value of experienceDanny Diep, Sara de la Salle, Julien Thibault Lévesque, et al.
Psychological Medicine|May 8, 2026
Cognitive effects of intravenous Ketamine in treatment-resistant depression: A systematic reviewLou-Anne Chavigny, Véronique Desbeaumes Jodoin, Nicolas Garel, et al.
Journal of Affective Disorders|April 19, 2023
Intravenous ketamine for treatment-resistant depression patients who have failed to respond to transcranial magnetic stimulation: A case seriesOlivier Payette, Paul Lespérance, Véronique Desbeaumes Jodoin, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Palliative & Supportive Care|October 23, 2025
Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case reportHouman Farzin, Benjamin Koren, Héléna Ferrier, et al.
Journal of Clinical Psychopharmacology|February 29, 2024
Rapid Improvement of Post-Partum Depression With Subanesthetic Racemic KetamineÉmilie Guay, Marie-Josée Brouillette, Jessica Drury, et al.
International Clinical Psychopharmacology|April 26, 2021
Adjunctive music improves the tolerability of intravenous ketamine for bipolar depressionKyle T Greenway, Nicolas Garel, Nathalie Goyette, et al.
Journal of Affective Disorders|June 1, 2024
The impact of antidepressant treatment on the network structure of neurocognition and core emotional depressive symptoms among depressed individuals with a history of suicide attempt: An 8-week clinical studyStéphane Richard-Devantoy, Marcelo T Berlim, Nicolas Garel, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 24, 2025
Effect of Cariprazine on Outcomes in Older-aged and Younger-aged Patients with Bipolar I Disorder: A Post-hoc AnalysisNicolas Garel, Annemieke Dols, Jun Yu, et al.
Journal of Psychiatry & Neuroscience : JPN|May 12, 2023
Mindfulness-based intervention for benzodiazepine deprescription in hemodialysis patients with anxiety and depressive symptomsNicolas Garel, Christina Rigas, Mona Ben M'rad, et al.
International Clinical Psychopharmacology|May 9, 2023
Ketamine for depression: a potential role in requests for Medical Aid in Dying?Nicolas Garel, Michka Nazon, Kamran Naghi, et al.
Expert Review of Clinical Pharmacology|January 27, 2025
The ketamine chameleon: history, pharmacology, and the contested value of experienceDanny Diep, Sara de la Salle, Julien Thibault Lévesque, et al.
Psychological Medicine|May 8, 2026
Cognitive effects of intravenous Ketamine in treatment-resistant depression: A systematic reviewLou-Anne Chavigny, Véronique Desbeaumes Jodoin, Nicolas Garel, et al.
Journal of Affective Disorders|April 19, 2023
Intravenous ketamine for treatment-resistant depression patients who have failed to respond to transcranial magnetic stimulation: A case seriesOlivier Payette, Paul Lespérance, Véronique Desbeaumes Jodoin, et al.
Pageof 4